Insider Trading May 14, 2026 08:04 PM

Insider Activity Highlights Buying Spree by Biglari Chairman's Fund in BH Stock

Sardar Biglari and affiliated entities acquired over $13 million worth of Class B common stock during a period when the company reported losses.

By Priya Menon BH

Chairman Sardar Biglari, through his associated funds, executed a significant purchase of Biglari Holdings Inc. (BH) Class B common stock between May 12 and May 14, 2026. The buying spree totaled over $13 million for 52,674 shares, occurring shortly after the stock experienced a notable decline. This insider activity takes place against a backdrop where BH reported a loss of $72.13 per share over the last twelve months, although it maintains strong liquidity metrics.

Insider Activity Highlights Buying Spree by Biglari Chairman's Fund in BH Stock
BH

Key Points

  • Insider confidence: The large-scale purchase of stock by the Chairman and his associated funds, despite recent price declines and reported losses, suggests internal belief in the company's future value.
  • Financial stability vs. profitability: While Biglari Holdings reports an annual loss per share ($72.13), its current ratio (2.47) indicates strong liquidity, suggesting sufficient liquid assets to cover short-term debts.
  • Corporate governance continuity: Shareholders affirmed the board's structure by re-electing all five directors and approving the appointment of the company's auditor.

Chairman Sardar Biglari, along with related investment vehicles including Biglari Capital Corp. and The Lion Fund, L.P., recently executed substantial purchases of Biglari Holdings Inc.'s (BH) Class B common stock. These transactions, which were formally reported via a Form 4 filing, spanned three consecutive business days: May 12 through May 14, 2026.

The buying activity represented a considerable investment by the insiders. The reporting parties collectively acquired 52,674 shares of Biglari Holdings Class B common stock, totaling $13,439,603. These purchases were executed at weighted average prices that ranged between $249.84 and $260.36 per share.


The structure of the transactions indicates an indirect investment mechanism. The Lion Fund, L.P., was the entity through which these shares were acquired. Biglari Capital Corp. functions as the general partner for The Lion Fund, L.P., and Mr. Biglari himself is recognized as the sole member, Chairman, and Chief Executive Officer of Biglari Capital Corp. Consequently, both Biglari Capital Corp. and Mr. Biglari are considered potential beneficial owners of the shares held by The Lion Fund, L.P.

The acquisition details vary across the three days:

  • On May 12, 2026, The Lion Fund, L.P., purchased 22,965 shares at a weighted average price of $249.84 per share. Individual transaction prices for this day fluctuated between $244.18 and $256.54.
  • The following day, May 13, saw the acquisition of an additional 15,358 shares at a weighted average price of $260.36 per share. Transaction prices on this date ranged from $252.40 to $265.00.
  • The final reported purchase on May 14 involved 14,351 shares, which were bought at a weighted average price of $258.06 per share. Individual transaction prices for this day ranged from $256.50 to $259.46.

The timing of these insider purchases is noteworthy because it occurred while the stock was trading near $258, following a sharp 16% decline in value over the preceding week.


This significant insider buying activity comes at a time when Biglari Holdings operates within a challenging financial environment. The company has reported a loss of $72.13 per share over the trailing twelve months. While BH generated substantial revenue amounting to $397.71 million, it remains fundamentally unprofitable.

Despite the current losses, the balance sheet metrics suggest a degree of operational stability. According to InvestingPro analysis, the company maintains a healthy current ratio of 2.47. This figure indicates that its liquid assets comfortably exceed its short-term financial obligations.

Furthermore, the article details the current ownership structure following these purchases: The Lion Fund, L.P., now indirectly holds 1,398,104 shares of Class B common stock. Biglari Capital Corp. indirectly maintains 71,855 shares of Class B common stock and 25,663.1 shares of Class A common stock. Sardar Biglari personally owns 1 share of Class B common stock and 0.1 shares of Class A common stock. Additionally, Mr. Biglari indirectly controls 128,811.7 shares of Class A common stock through The Lion Fund, L.P., and 25,663.1 shares of Class A common stock via Biglari Capital Corp.


In corporate governance news, Biglari Holdings Inc. recently held its annual shareholders’ meeting. Attendance was robust, with approximately 95% of the company's outstanding Class A common stock represented either in person or by proxy. During this meeting, shareholders addressed two key proposals. First, they voted on the election of directors, which resulted in the re-election of all five existing board nominees. Second, the appointment of the company's auditor was approved by the shareholders. These events contribute to Biglari Holdings' ongoing corporate governance efforts.

Risks

  • Unprofitability: The primary financial risk highlighted is that, despite generating $397.71 million in revenue, the company reported a loss of $72.13 per share over the past twelve months.
  • Valuation concerns: An analysis noted that, relative to its Fair Value, the stock currently appears overvalued, which presents a potential market risk if valuation multiples do not align with future performance improvements.
  • Market volatility backdrop: The buying spree occurred after the stock experienced a sharp 16% decline over the previous week, indicating continued susceptibility to rapid price swings and market sentiment shifts.

More from Insider Trading

WillScot Director Reports Significant Stock Sales Amid Market Valuation Observations May 14, 2026 Insider Activity and Corporate Updates at Abundia Global Impact Group May 14, 2026 Analysis of Insider Transactions and Financial Performance at Innodata Inc. May 14, 2026 Protagonist Therapeutics CEO Sells Shares Following Option Exercise Amid Analyst Optimism May 14, 2026 Shattuck Labs' CTO Sells Shares Following Stock Surge Amid Positive Drug Candidate News May 14, 2026